These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26509444)

  • 41. Monosomal karyotype predicts adverse prognosis in patients diagnosed with chronic myelomonocytic leukemia: a single-institution experience.
    Alsahlawi A; Alkhateeb H; Patnaik M; Begna K; Elliott M; Hogan WJ; Litzow M; Al-Kali A
    Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):e39-41. PubMed ID: 25027568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
    Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
    Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
    Elena C; Gallì A; Such E; Meggendorfer M; Germing U; Rizzo E; Cervera J; Molteni E; Fasan A; Schuler E; Ambaglio I; Lopez-Pavia M; Zibellini S; Kuendgen A; Travaglino E; Sancho-Tello R; Catricalà S; Vicente AI; Haferlach T; Haferlach C; Sanz GF; Malcovati L; Cazzola M
    Blood; 2016 Sep; 128(10):1408-17. PubMed ID: 27385790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic myelomonocytic leukemia: myeloproliferative variant.
    Onida F; Beran M
    Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.
    Federmann B; Abele M; Rosero Cuesta DS; Vogel W; Boiocchi L; Kanz L; Quintanilla-Martinez L; Orazi A; Bonzheim I; Fend F
    Hum Pathol; 2014 Dec; 45(12):2471-9. PubMed ID: 25305095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-nucleotide polymorphism-array improves detection rate of genomic alterations in core-binding factor leukemia.
    Costa AR; Vasudevan A; Krepischi A; Rosenberg C; Chauffaille Mde L
    Med Oncol; 2013; 30(2):579. PubMed ID: 23636907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia.
    Patnaik MM; Barraco D; Lasho TL; Finke CM; Hanson CA; Ketterling RP; Gangat N; Tefferi A
    Am J Hematol; 2017 Jan; 92(1):56-61. PubMed ID: 27733013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization.
    Lo KC; Bailey D; Burkhardt T; Gardina P; Turpaz Y; Cowell JK
    Genes Chromosomes Cancer; 2008 Mar; 47(3):221-37. PubMed ID: 18050302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Additional genomic aberrations identified by single nucleotide polymorphism array-based karyotyping in an acute myeloid leukemia case with isolated del(20q) abnormality.
    Hahm C; Mun YC; Seong CM; Chung WS; Huh J
    Ann Lab Med; 2012 Nov; 32(6):445-9. PubMed ID: 23130347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.
    Wang SA; Galili N; Cerny J; Sechman E; Chen SS; Loew J; Liu Q; Fadare O; Hasserjian R; Jones D; Qawi H; Woda B; Raza A
    Am J Clin Pathol; 2006 Nov; 126(5):789-97. PubMed ID: 17050076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia.
    Kim HY; Lee KO; Park S; Jang JH; Jung CW; Kim SH; Kim HJ
    Ann Lab Med; 2018 Nov; 38(6):495-502. PubMed ID: 30027691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.
    Chen C; Heng EYH; Lim AST; Lau LC; Lim TH; Wong GC; Tien SL
    Int J Lab Hematol; 2019 Aug; 41(4):561-571. PubMed ID: 31112375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
    Tiu RV; Gondek LP; O'Keefe CL; Elson P; Huh J; Mohamedali A; Kulasekararaj A; Advani AS; Paquette R; List AF; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
    Blood; 2011 Apr; 117(17):4552-60. PubMed ID: 21285439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays.
    Ahmad A; Iqbal MA
    Curr Med Chem; 2012; 19(22):3739-47. PubMed ID: 22680919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors.
    Dougherty MJ; Tooke LS; Sullivan LM; Hakonarson H; Wainwright LM; Biegel JA
    Cancer Genet; 2012; 205(1-2):42-54. PubMed ID: 22429597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category.
    Huh J; Jung CW; Kim HJ; Kim YK; Moon JH; Sohn SK; Kim HJ; Min WS; Kim DH
    Genes Chromosomes Cancer; 2013 Jan; 52(1):44-55. PubMed ID: 23023762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.
    Arenillas L; Mallo M; Ramos F; Guinta K; Barragán E; Lumbreras E; Larráyoz MJ; De Paz R; Tormo M; Abáigar M; Pedro C; Cervera J; Such E; José Calasanz M; Díez-Campelo M; Sanz GF; Hernández JM; Luño E; Saumell S; Maciejewski J; Florensa L; Solé F
    Genes Chromosomes Cancer; 2013 Dec; 52(12):1167-77. PubMed ID: 24123380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia.
    Tang G; Fu B; Hu S; Lu X; Tang Z; Li S; Jabbar K; Khoury JD; Medeiros LJ; Wang SA
    Am J Hematol; 2015 Oct; 90(10):882-7. PubMed ID: 26148174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.
    Baughn LB; Biegel JA; South ST; Smolarek TA; Volkert S; Carroll AJ; Heerema NA; Rabin KR; Zweidler-McKay PA; Loh M; Hirsch B
    Cancer Genet; 2015; 208(1-2):1-18. PubMed ID: 25678190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.